AMC Entertainment
GameStop
Zomedica
Churchill Capital Corp IV
Ideanomics
Nokia
QuantumScape
Ford Motor
Aphria
Stryker (SYK) stock forecast for 2024
The forecast has been updated: December 1, 2023 9:39
Stryker stock price online today
Analyst Target Price
321.57Dividend Date
31.10.2023Ex Dividend Date
28.09.2023Last Split Factor
Last Split Date
01.01.1970Should you buy or sell Stryker stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? Stryker stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $321.57 target price for Stryker stock stock.
Today 200 Day Moving Average is the support level (277.71 $).
50 Day Moving Average is the support level (284.93 $).
SYK Forecast for 2024
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 260.57 | 254.47 | 271.51 | 6.28 % |
| Feb | 273.23 | 263.56 | 277.82 | 5.13 % |
| Mar | 268.80 | 257.19 | 278.48 | 7.64 % |
| Apr | 272.19 | 268.76 | 278.07 | 3.35 % |
| May | 256.84 | 249.90 | 264.54 | 5.53 % |
| Jun | 259.15 | 249.35 | 267.55 | 6.80 % |
| Jul | 272.06 | 259.16 | 285.11 | 9.10 % |
| Aug | 267.65 | 264.28 | 273.91 | 3.52 % |
| Sep | 269.58 | 260.84 | 279.44 | 6.66 % |
| Oct | 272.81 | 263.64 | 278.54 | 5.35 % |
| Nov | 275.92 | 265.99 | 281.38 | 5.47 % |
| Dec | 267.48 | 258.33 | 275.50 | 6.23 % |
The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Stryker stock.
Stryker overview
Stryker Address
2825 AIRVIEW BLVD, KALAMAZOO, MI, USMarket Capitalization
103 835 099 000 $EBITDA
4 794 000 000PE Ratio
38.62PEG Ratio
2.853Dividend Per Share
2.945Dividend Yield
0.011EPS
7.08Quarterly Earnings Growth YOY
0.122Quarterly Revenue Growth YOY
0.112Trailing PE
38.62Forward PE
25.51EV To Revenue
5.98EV To EBITDA
27.8952 Week High
306.9352 Week Low
200.6150 Day Moving Average
284.93200 Day Moving Average
277.71Shares Outstanding
379778000Shares Float
Shares Short Prior Month
Short Ratio
Percent Insiders
Percent Institutions
Stryker stock forecast for this year
Stryker stock forecast for Jan 2024.
Estimated Average Forecasted Stryker Price: 260.57. Positive monthly dynamics of the instrument is expected with 6.276% volatility is expected.
Pessimistic forecast: 254.47
Optimistic: 271.51
Stryker stock forecast for Feb 2024.
Estimated Average Forecasted Stryker Price: 273.23. Positive monthly dynamics of the instrument is expected with 5.134% volatility is expected.
Pessimistic forecast: 263.56
Optimistic: 277.82
Stryker stock forecast for Mar 2024.
Estimated Average Forecasted Stryker Price: 268.80. Negative monthly dynamics of the instrument is expected with 7.645% volatility is expected.
Pessimistic forecast: 257.19
Optimistic: 278.48
Stryker stock forecast for Apr 2024.
Estimated Average Forecasted Stryker Price: 272.19. Positive monthly dynamics of the instrument is expected with 3.348% volatility is expected.
Pessimistic forecast: 268.76
Optimistic: 278.07
Stryker stock forecast for May 2024.
Estimated Average Forecasted Stryker Price: 256.84. Negative monthly dynamics of the instrument is expected with 5.534% volatility is expected.
Pessimistic forecast: 249.90
Optimistic: 264.54
Stryker stock forecast for Jun 2024.
Estimated Average Forecasted Stryker Price: 259.15. Positive monthly dynamics of the instrument is expected with 6.800% volatility is expected.
Pessimistic forecast: 249.35
Optimistic: 267.55
Stryker stock forecast for Jul 2024.
Estimated Average Forecasted Stryker Price: 272.06. Positive monthly dynamics of the instrument is expected with 9.103% volatility is expected.
Pessimistic forecast: 259.16
Optimistic: 285.11
Stryker stock forecast for Aug 2024.
Estimated Average Forecasted Stryker Price: 267.65. Negative monthly dynamics of the instrument is expected with 3.518% volatility is expected.
Pessimistic forecast: 264.28
Optimistic: 273.91
Stryker stock forecast for Sep 2024.
Estimated Average Forecasted Stryker Price: 269.58. Positive monthly dynamics of the instrument is expected with 6.656% volatility is expected.
Pessimistic forecast: 260.84
Optimistic: 279.44
Stryker stock forecast for Oct 2024.
Estimated Average Forecasted Stryker Price: 272.81. Positive monthly dynamics of the instrument is expected with 5.348% volatility is expected.
Pessimistic forecast: 263.64
Optimistic: 278.54
Stryker stock forecast for Nov 2024.
Estimated Average Forecasted Stryker Price: 275.92. Positive monthly dynamics of the instrument is expected with 5.472% volatility is expected.
Pessimistic forecast: 265.99
Optimistic: 281.38
Stryker stock forecast for Dec 2024.
Estimated Average Forecasted Stryker Price: 267.48. Negative monthly dynamics of the instrument is expected with 6.233% volatility is expected.
Pessimistic forecast: 258.33
Optimistic: 275.50
Other Healthcare sector assets
| Name | Symbol | Last Close Price | Change |
|---|---|---|---|
 Abbott Laboratories
|
ABT | 95.78 (23.10.2023) | -1.03 % |
 AbbVie Inc.
|
ABBV | 143.41 (01.12.2023) | 0.72 % |
 Aeterna Zentaris Inc.
|
AEZS | 2.87 (14.07.2023) | -1.03 % |
 Allakos Inc.
|
ALLK | 4.65 (14.07.2023) | -2.11 % |
 Allogene Therapeutics, Inc.
|
ALLO | 4.96 (14.07.2023) | -4.89 % |
 Amgen Inc.
|
AMGN | 273.06 (23.10.2023) | -2.06 % |
|
Aphria Inc.
|
APHA | 15.38 (07.05.2021) | 0.00 % |
 Atara Biotherapeutics, Inc.
|
ATRA | 1.83 (14.07.2023) | -8.04 % |
 Aurora Cannabis Inc.
|
ACB | 0.534 (14.07.2023) | -5.94 % |
 Becton Dickinson and Company
|
BDX | 259.39 (14.07.2023) | -0.22 % |
 Biogen Inc.
|
BIIB | 278.4 (17.07.2023) | -0.19 % |
 Biohaven Pharmaceutical Holding Company Ltd.
|
BHVN | 27.37 (20.10.2023) | 1.60 % |
 BioNTech SE
|
BNTX | 92.52 (23.10.2023) | 1.77 % |
 bluebird bio, Inc.
|
BLUE | 3.03 (14.07.2023) | -8.46 % |
 Boston Scientific Corp.
|
BSX | 49.52 (13.10.2023) | 1.81 % |
 Bristol-Myers Squibb Company
|
BMY | 61.85 (17.07.2023) | -0.15 % |
 Canopy Growth Corp.
|
CGC | 0.3841 (14.07.2023) | -40.91 % |
 Castle Biosciences, Inc.
|
CSTL | 12.8 (23.10.2023) | 0.00 % |
|
CLOVER HEALTH INVESTMENTS, CORP
|
CLOV | 3.16 (07.01.2022) | -5.67 % |
 Eli Lilly and Company
|
LLY | 242.27 (04.02.2022) | 0.00 % |
 Emergent BioSolutions Inc.
|
EBS | 7.21 (14.07.2023) | -0.96 % |
 Exelixis, Inc.
|
EXEL | 18.56 (17.06.2022) | 5.63 % |
 G1 Therapeutics, Inc.
|
GTHX | 2.41 (14.07.2023) | -0.82 % |
 Gilead Sciences, Inc.
|
GILD | 77.19 (14.07.2023) | 0.63 % |
 GlaxoSmithKline plc
|
GSK | 34.53 (14.07.2023) | -0.78 % |
 GoodRx Holdings, Inc.
|
GDRX | 7.46 (14.07.2023) | 1.77 % |
 GW Pharmaceuticals plc.
|
GWPH | 218.96 (05.05.2021) | 0.00 % |
 Incyte Corp.
|
INCY | 61.08 (17.07.2023) | -1.10 % |
 Inovio Pharmaceuticals, Inc.
|
INO | 0.5392 (17.07.2023) | 2.70 % |
 Johnson & Johnson
|
JNJ | 166.11 (13.04.2023) | 1.34 % |
 Medtronic plc.
|
MDT | 72.39 (23.10.2023) | -0.43 % |
 Merck & Co., Inc.
|
MRK | 105.57 (17.07.2023) | -1.65 % |
 Moderna, Inc.
|
MRNA | 121.35 (14.07.2023) | -4.15 % |
 Novartis AG
|
NVS | 98.83 (14.07.2023) | 0.51 % |
 Novavax, Inc.
|
NVAX | 8.68 (14.07.2023) | -6.06 % |
 ObsEva SA
|
OBSV | 0.05 (14.07.2023) | 0.00 % |
 OrganiGram Holdings Inc.
|
OGI | 1.49 (17.07.2023) | -4.49 % |
 Pfizer Inc.
|
PFE | 30.84 (23.10.2023) | 0.62 % |
 Regeneron Pharmaceuticals, Inc.
|
REGN | 721.61 (17.07.2023) | 0.43 % |
 Sanofi
|
SNY | 52.68 (14.07.2023) | 1.07 % |
 Schrodinger, Inc.
|
SDGR | 21.99 (23.10.2023) | 0.05 % |
 Senseonics Holdings, Inc.
|
SENS | 0.875 (14.07.2023) | -3.90 % |
 Sorrento Therapeutics, Inc.
|
SRNE | 0.35 (14.07.2023) | -0.28 % |
|
Stryker Corp.
|
SYK | 263.57 (23.10.2023) | -0.80 % |
 Sundial Growers Inc.
|
SNDL | 1.42 (17.07.2023) | 1.43 % |
 Teva Pharmaceutical Industries Lim. (TEVA)
|
TEVA | 8.18 (23.10.2023) | 0.74 % |
 Thermo Fisher Scientific Inc.
|
TMO | 461.81 (23.10.2023) | -0.55 % |
 Tilray, Inc.
|
TLRY | 1.69 (17.07.2023) | 1.81 % |
 UnitedHealth Group, Inc.
|
UNH | 527.03 (20.10.2023) | -0.87 % |
 Veeva Systems Inc.
|
VEEV | 178.84 (01.12.2023) | 2.60 % |
|
Zomedica Corp.
|
ZOM | 0.2114 (14.07.2023) | -5.41 % |
 Zynerba Pharmaceuticals, Inc.
|
ZYNE | 1.3 (11.10.2023) | 0.00 % |
Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.